CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Onyx Therapeutics, Inc. v. Fresenius Kabi USA, LLC

1:16-cv-01012

Overview

Case Number 1:16-cv-01012
Filing Date 2016-11-01
Status Terminated
Termination Date 2019-05-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Fresenius Kabi USA, Inc. Operating Company

Represented By

4 Attorneys Listed

Joshua A. Whitehill

Email: jwhitehill@kasowitz.com

Aviv Zalcenstein

Email: azalcenstein@goodwinlaw.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

David M. Fry

JPMorgan Chase & Co.

Tel: +1 (302) 455-3374

JPMorgan Chase & Co., 4041 Ogletown Stanton Road

Fresenius Kabi USA, LLC Operating Company

Represented By

6 Attorneys Listed

Sundar Subramanyam

Email: ssubramanyam@goodwinprocter.com

John T. Bennett

Email: jbennett@goodwinlaw.com

Huiya Wu

Email: HWu@goodwinlaw.com

Aviv Zalcenstein

Email: azalcenstein@goodwinlaw.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

David M. Fry

JPMorgan Chase & Co.

Tel: +1 (302) 455-3374

JPMorgan Chase & Co., 4041 Ogletown Stanton Road

Fresenius Kabi Oncology Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Fresenius Kabi Pharmaceuticals Holding, Inc. Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

David M. Fry

JPMorgan Chase & Co.

Tel: +1 (302) 455-3374

JPMorgan Chase & Co., 4041 Ogletown Stanton Road

Plaintiff

Onyx Therapeutics, Inc. Operating Company

Represented By

6 Attorneys Listed

Wendy A. Whiteford

Email: wendy@amgen.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Margaret A. O'Boyle

Email: moboyle@omm.com

Lisa Barons Pensabene

O'Melveny & Myers LLP

Tel: +1 (212) 326-2077
Fax: +1 (212) 326-2061

7 Times Square, Times Square Tower, New York, NY 10036

Brian Kao

UNDELIVERABLE 6/11/2020

UNDELIVERABLE 6/11/2020

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

9

Dispositive

0

Granted

0

Denied

0

Pending / Review

5

Motions by Category

Procedural / Extension Motion 8 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for purposes of discovery and all paper...
Entry #27 • 2017-04-18 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (21 in 1:16-cv-01036-LPS, 17 in 1:16-cv-01000-LPS, 18 in 1:16-cv-01013-LPS, 18 in 1:16-cv-01001-LPS, 22 in 1:16-cv-01039-LPS, 25 in 1:16-cv-01012...
Entry #— • 2017-03-27
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to March 29, 2017 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Ent...
Entry #25 • 2017-03-22 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 21 STIPULATION TO EXTEND TIME for Plaintiff to answer, move, or otherwise respond to Defendant/Counterclaim-Plaintiff's counterclaim to February ...
Entry #— • 2017-01-27
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiff to answer, move, or otherwise respond to Defendant/Counterclaim-Plaintiff's counterclaim to February 3, 2017 - filed by...
Entry #21 • 2017-01-26 Document →
Procedural / Extension Motion Pending
SO ORDERED - re 17 STIPULATION TO EXTEND TIME to Respond to the Complaint to January 6, 2017 filed by Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC, Freseni...
Entry #— • 2016-12-27

Docket Entries

(65 total)
Pleading / Complaint

COMPLAINT for Patent Infringement filed against Fresenius Kabi Oncology Limited, Fresenius Kabi Pharmaceuticals Holding, Inc., Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2023065.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A - I, # 2 Civil Cover Sheet)(klc) (Entered: 11/01/2016)

Entry #1 • 2016-11-01
1
Pleading / Complaint

COMPLAINT for Patent Infringement filed against Fresenius Kabi Oncology Limited, Fresenius Kabi Pharmaceuticals Holding, Inc., Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2023065.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A - I, # 2 Civil Cover Sheet)(klc) (Entered: 11/01/2016)

Entry #1 • 2016-11-01
2
Pleading / Complaint

COMPLAINT for Patent Infringement filed against Fresenius Kabi Oncology Limited, Fresenius Kabi Pharmaceuticals Holding, Inc., Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2023065.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A - I, # 2 Civil Cover Sheet)(klc) (Entered: 11/01/2016)

Entry #1 • 2016-11-01
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (klc) (Entered: 11/01/2016)

Entry #2 • 2016-11-01
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 19, 2016. Date of Expiration of Patent: See Anda Form.Thirty Month Stay Deadline: 1/20/2020. (klc) (Entered: 11/01/2016)

Entry #3 • 2016-11-01
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc